Amy L. Burroughs - 25 Jun 2025 Form 4 Insider Report for Terns Pharmaceuticals, Inc. (TERN)

Role
Chief Executive Officer, Director
Signature
/s/ David Strauss, as Attorney-in-Fact for Amy L. Burroughs
Issuer symbol
TERN
Transactions as of
25 Jun 2025
Net transactions value
+$90,230
Form type
4
Filing time
25 Jun 2025, 18:08:58 UTC
Previous filing
30 May 2025
Next filing
06 Jan 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Burroughs Amy L. Chief Executive Officer, Director C/O TERNS PHARMACEUTICALS, INC., 1065 EAST HILLSDALE BLVD., SUITE 100, FOSTER CITY /s/ David Strauss, as Attorney-in-Fact for Amy L. Burroughs 25 Jun 2025 0001872564

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TERN Common Stock Purchase $90,230 +23,314 +98% $3.87 47,083 25 Jun 2025 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 4,160 shares acquired by the reporting person under the Issuer's 2021 Employee Stock Purchase Plan on May 31, 2025.